|
Match
|
Document |
Document Title |
|
|
6197829 |
External preparation of 2-amino-2-(2-(4-octylphenyl)ethyl) propane-1,3-diol or pharmaceutically acceptable salts thereof for topical administration
An external preparation for topical administration which aims at inhibiting rejection reactions at organ or bone marrow transplantation or treating autoimmune diseases or allergic diseases and...
|
|
|
6184222 |
Treatment of conduct disorder
Norepinephrine reuptake inhibitors are used to treat conduct disorder.
|
|
|
6184254 |
Methods of identifying modulators of perivascular sensory nerve Ca2+ receptors
Methods of identifying compounds that relax or stimulate arterial tension through their action on perivascular sensory nerve calcium receptors are described. Compounds identified through such...
|
|
|
6166092 |
Fluorocarbon compositions for pulmonary therapy
Biocompatible fluorocarbon compositions are provided which may be used for the delivery of bioactive agents to the pulmonary air passages of a patient. Preferred compositions comprise a...
|
|
|
6162833 |
Photostable aqueous solution comprising benzyl alcohol derivatives
Aqueous solution, including at least one of optically active (-)-(R)-α-((tert-butylamino)methyl)-2-chloro-4-hydroxybenzy
l alcohol represented by the following formula: ##STR1## and...
|
|
|
6153647 |
Method for augmenting the inotropic effects of β-adrenergic agonists using pyruvate therapy
A method for treating medical patients suffering from cardiac trauma by co-administering pyruvate with a β-adrenergic agonist. This method for treating cardiac trauma, such as ischemic reperfusion...
|
|
|
6136864 |
Denaturants for sympathomimetic amine salts
A pharmaceutical composition has an acid salt of a sympathomimetic amine; and a denaturant of (i) at least one gum or viscosity modifier, and (ii) at least one surfactant, wherein the gum or...
|
|
|
6133321 |
Method for the reduction of stress in meat producing animals and meat produced from slaughtered animals treated thereby
A method of reducing the stress in meat producing animals and of improving the quality of the meat produced from slaughtering said animals, while reducing the number of animals lost due to...
|
|
|
6121329 |
Topical administration of 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol
An external preparation for topical administration which aims at inhibiting rejection reactions at organ or bone marrow transplantation or treating autoimmune diseases or allergic diseases and...
|
|
|
6114382 |
Methods for treating inflammatory bowel disease
The present invention provides novel compositions and methods relating to the treatment of Inflammatory Bowel Disease ("IBD"), most notably, Ulcerative Colitis, Crohn's Disease, Colitis and...
|
|
|
6110974 |
Methods of accelerating muscle growth and improving feed efficiency in animals by using optically pure eutomers of adrenergic beta-2 receptor agonists, and food supplements containing the same
Method for improving health, survival and muscle growth rate of animals, while reducing carcass fat and improving feed efficiency by administering an optically pure eutomer of an adrenergic beta-2...
|
|
|
6087350 |
Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
The present invention provides a method of killing a cell by first administering to the cell a vitamin D derivative and subsequently administering to the cell a cytotoxic agent. Where the cell is...
|
|
|
6071971 |
Desformoterol compositions useful for inducing bronchodilation
The (R,R)-, (S,S)-, (R,S)-, (R,S)-isomers of 3-amino-4-hydroxy-α-[[[2-(4-methoxyphenyl)-1-methylethyl]am
ino]methy l]-benzenemethanol (D) ##STR1## are disclosed, as well as an efficient method for...
|
|
|
6066676 |
Pharmaceutical composition and methods for using it
Disclosed is a method of treating problems or disorders of the human nervous system or a method of imparting an anaesthetic effect, by applying to a patient in need of such treatment a...
|
|
|
6051605 |
Method of treating psychosis and schizophrenia
This invention relates to compounds that are antagonists of dopamine D4 receptors, and to methods of treating psychosis and schizophrenia using a compound that is an antagonist of dopamine D4...
|
|
|
6037358 |
Decongestant/antihistaminic compositions
Tannate compositions consisting essentially of phenylephrine tannate and chiorpheniramine tannate which are effective when administered orally for the symptomatic relief of coryza associated with...
|
|
|
6028070 |
Treatment of oppositional defiant disorder
Norepinephrine reuptake inhibitors are used to treat oppositional defiant disorder.
|
|
|
6020305 |
Treatment of stress-induced skin disease by corticotropin releasing hormone antagonists and skin mast cell degranulation inhibitors
A method of reducing or blocking a stress-related atopic skin disease such as exzema or uticaria in a subject comprising administering to the patient an agent that antagonizes CRH-induced...
|
|
|
6015837 |
Method for treating scoliosis with β2-adrenoceptor agonists
A method of treating scoliosis by adminstering β 2 adrenergic agonists in amounts sufficient to correct the condition.
|
|
|
6011066 |
Method for treating septic shock
A method for the treating septic shock in a patient comprises administering to the patient a therapeutically-effective amount of a composition comprising a compound having the formula (I): ##STR1##...
|
|
|
5998478 |
Timed release tablet comprising naproxen and pseudoephedrine
Disclosed herein is a pharmaceutical composition comprising naproxen and the decongestant pseudoephedrine in a time release tablet form in the therapy of sinusitis, or sinus headaches, generally...
|
|
|
5972919 |
Combination of a bronchodilator and a steroidal anti-inflammatory drug for the treatment of respiratory disorders, as well as its use and the preparation thereof
Effective amounts of formoterol (and/or a physiologically acceptable salt and/or solvate thereof) and budesonide are used in combination for simultaneous, sequential or separate administration by...
|
|
|
5972932 |
Anesthetic method and composition
The present invention provides a method for providing anesthesia using a composition comprising olanzapine and one or more opioids.
|
|
|
5965622 |
Desformoterol and process for its preparation
The (R,R)-, (S,S)-, (R,S)-, (R,S)- isomers of 3-amino-4-hydroxy-α-[[[2-(4-methoxyphenyl)-1-methylethyl]am
ino]methy l]-benzenemethanol (D) ##STR1## are disclosed, as well as an efficient method...
|
|
|
5958836 |
Algistats
The present invention relates to a method for the prevention of growth of algae by incorporating within liquids or coating on surfaces certain substituted amino alcohols. More precisely, this...
|
|
|
5955439 |
Pharmaceutical aerosol containing at least one sugar
This invention relates to aerosol formulations of use for the administration of medicaments by inhalation and in particular to a pharmaceutical aerosol formulation which comprises (a) particulate...
|
|
|
5952387 |
Photostable aqueous solution containing benzyl alcohol derivatives
Aqueous solution, including at least one of optically active (-)-(R)-α-((tert-butylamino)methyl)-2-chloro-4-hydroxybenzy
l alcohol represented by the following formula: ##STR1## and...
|
|
|
5948414 |
Herbal based nasal spray
This invention relates to an improved herbal-based decongestant and antihistamine nasal spray which includes known constituents in specific ratios and further includes a saponin. The invention...
|
|
|
5942497 |
Purine compound and catecholamine compound containing compositions and methods for administration
A purine compound, which has a desired and an undesired effect when a dosage sufficient to induce the desired effect is administered to a mammal, is combined with a counteracting agent, wherein the...
|
|
|
5929101 |
Use of insulin sensitizing agents to treat hypertension
The present invention provides a method for treatin hypertension in insulin resistant patients comprising the administration of an insulin sensitizing agent, particularly ciglitazone or pioglitazone.
|
|
|
5925682 |
Epinephrine as inhibitor of cancerous tumors
A method for reducing cancerous tumors is disclosed. The method includes administering to a mammal an effective amount of epinephrine. In another embodiment, the mammal is immediately immobilized...
|
|
|
5916923 |
Venlafaxine for the treatment of generalized anxiety disorder
This invention provides a method of treating obesity, generalized anxiety disorder, post-traumatic stress disorder, late luteal phase disphoric disorder (premenstrual syndrome), attention deficit...
|
|
|
5910513 |
Substituted benzyl derivatives of polyalkylene polyamines and their use in cosmetic and pharmaceutical compositions
A compound being a substituted benzyl derivative of polyalkylene polyamine and corresponding to the following formula: ##STR1## in which: n and m=2, 3 or 4, p=2 or 3, x=0, 1 or 2, R 1 and R 4 ,...
|
|
|
5861435 |
Method for preventing settlement of aquatic fouling organisms
A method for preventing settlement of aquatic fouling organisms on surface of an aquatic structure without environmental hazard is provided. The method is based upon absolutely novel concept to...
|
|
|
5849265 |
Pharmaceutical aerosol formulation comprising a medicament, a propellant and a fluorinated surfactant
A pharmaceutical aerosol formulation which comprises particulate medicament, a fluorocarbon of hydrogen-containing chlorofluorocarbon propellant and a surfactant of general formula (I), wherein n...
|
|
|
5849801 |
4-amino-5-oxy-2,6,6-trimethyl-2-cycloheptene compounds
4-amino-5-oxy-2,6,6-tri methyl-2-cycloheptene compounds represented by the following general formula: ##STR1## (wherein R 1 and R 2 each independently represent a hydrogen atom, an alkyl group...
|
|
|
5827893 |
Mechanical and pharmacological therapies to treat cardiac arrest
A pharmaceutical composition is provided which comprises vasopressin and an adrenergic agent in combination with a pharmaceutically acceptable carrier. The pharmaceutical composition is effective...
|
|
|
5811438 |
Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
The compounds of the present invention are of the formula (I): A--X--(CH 2 ) n --Y--(CH 3 ) m --Z wherein: A is an non-steroidal anti-inflammatory agent (NSAIA); A--X is an ester or amide linkage...
|
|
|
5811131 |
Tasteless forms of basic drugs prepared by adsorption in situ
The present invention provides tasteless liquid compositions for oral ingestion of pharmacologically active agents having basic moieties, wherein the compositions contain the basic...
|
|
|
5798101 |
Herbal appetite suppressant and weight loss composition
The present invention is directed to herbal compositions which reduce weight, maintain weight loss over an extended period of time, and act as an appetite suppressant. The composition consists of...
|
|
|
5795880 |
Method and composition for treating obesity and related disorders in animals comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent
The invention describes a method and composition for treating obesity or related disorders in animals using an anorectic agent and dehydroepiandrosterone (DHEA). The composition effectively...
|
|
|
5776930 |
Pharmaceutical preparation
A method of preventing, treating, terminating and protecting against cardiac arrhythmias, such as atrial, supraventricular and ventricular ectopy, tachycardia, flutter or fibrillation, including...
|
|
|
5753713 |
Method for promoting hair growth
Disclosed is a pharmaceutical composition intended for the topical application to human skin, comprising (A) as an effective ingredient, a mixture comprising (1) an antibiotic medication; ...
|
|
|
5753247 |
Method of treating fungal infections
Disclosed is a pharmaceutical composition intended for the topical application to human skin, comprising (A) as an effective ingredient, a mixture comprising (1) an antibiotic medication; ...
|
|
|
5739165 |
Stabilized solid pharmaceutical preparation and method of producing the same
A solid pharmaceutical preparation containing 5 to 50% by weight of ibuprofen and 0.1 to 10% by weight of phenylpropionamide or a pharmaceutically acceptable salt thereof which are stabilized. The...
|
|
|
5733938 |
Combination of levobunolol and dipivefrin for topical ophthalmic use
Disclosed are pharmaceutical compositions comprising dipivefrin and levobunolol for topical ophthalmic delivery and a method of treatment comprising administering said composition when indicated...
|
|
|
5708036 |
Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol
The optically pure R-isomer of the adrenergic beta-2 agonist albuterol, substantially free of its corresponding S-isomer, has been found to potently inhibit premature uterine contractions in female...
|
|
|
5691385 |
Growth promotion
β-Phenethanolamines are effective in promoting growth and improving feed efficiency and leanness in animals.
|
|
|
5686413 |
Ractopamine and growth hormone combinations
Combined administration of a growth hormone related substance and ractopamine, cimaterol, clenbuterol, L-644,969, or albuterol to swine provides improved growth feed efficiency, and carcass...
|
|
|
5679325 |
Lidocaine aerosol anaesthetic
The composition of the present invention combines the local anaesthetic lidocaine in free base form and the non-CFC aerosol propellant HFC-134a (1,1,1,2-tetrafluoroethane; CF 3 CH 2 F) or HFC-227...
|